Figure 1. Time on study.
Each bar shows the number of 28-day cycles that a patient received the study treatment, oral ridaforolimus (22, 28, or 33 mg/m2) administered once daily for 5 days per week.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.